- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Neurofibromatose (ikke-malign) in China
I alt 13 resultater
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Ikke rekrutterer endnu
-
AstraZenecaTrukket tilbageNeurofibromatose type 1 | Plexiforme neurofibromer | Post-operativKina
-
AstraZenecaMerck Sharp & Dohme LLCAktiv, ikke rekrutterendeNeurofibromatose 1 | Neurofibroma PlexiformKina
-
Shenzhen Geno-Immune Medical InstituteShenzhen Children's Hospital; Shenzhen Hospital of Southern Medical UniversityUkendt
-
Li PengBetta Pharmaceuticals Co., Ltd.AfsluttetNeurofibromatose type 2 | Vestibulær SchwannomaKina
-
Beijing Tiantan HospitalShandong Simcere-Medgenn Bio-pharmaceutical Co., LtdAfsluttetNeurofibromatose type 2 | Vestibulær SchwannomaKina
-
Shanghai Kechow Pharma, Inc.RekrutteringNeurofibromatose 1 | Plexiforme neurofibromerKina
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.AfsluttetNeurofibromatose og maligne perifere nerveskedetumorerKina
-
Shanghai Ninth People's Hospital Affiliated to...RekrutteringNeurofibromatose 1 | Plexiformt neurofibromKina
-
Shanghai Fosun Pharmaceutical Industrial Development...RekrutteringNeurofibromatose 1 | NF1 | Plexiformt neurofibromKina
-
Shanghai Fosun Pharmaceutical Industrial Development...Aktiv, ikke rekrutterendeNeurofibromatose 1 | NF1 | Plexiformt neurofibromForenede Stater, Kina, Spanien
-
AstraZenecaMerck Sharp & Dohme LLCAktiv, ikke rekrutterendeNeurofibromatose 1 | Plexiformt neurofibrom (PN)Forenede Stater, Canada, Frankrig, Italien, Tyskland, Kina, Det Forenede Kongerige, Spanien, Japan, Den Russiske Føderation, Australien, Polen, Brasilien
-
AstraZenecaRekruttering